A population-based study of Helicobacter pylori: Does asymptomatic infection mean no gastroscopic lesions?
Authors:
- 11 December 2023
- journal article
- research article
- Published by Oxford University Press (OUP) in Postgraduate Medical Journal
- Vol. 100 (1181) , 179-186
Abstract
We determined the common clinical characteristics of patients infected with Helicobacter pylori (H. pylori) and investigated the relationship between H. pylori infection, and clinical symptoms, and gastroscopic manifestations. Our focus was specifically on the clinical manifestations in asymptomatic patients. We obtained the physical examination data of patients who underwent the 14C urea breath test between January 2018 and December 2020 at our Hospital. Basic demographic data, questionnaire data on clinical symptoms, and clinical examination data of the patients were also collected, and the correlation analysis was performed. A total of 2863 participants were included in the study. The overall H. pylori infection rate was 26.30%. The clinical symptoms between H. pylori-positive patients and H. pylori-negative patients did not differ significantly (P > .05). However, H. pylori-positive patients exhibited more severe gastroscopic manifestations (P < .001). The 14C urea breath test disintegrations per minute (DPM) values in H. pylori-positive patients correlated with their serum pepsinogen and gastrin-17 levels. With an increase in the DPM value, more combinations of clinical symptoms appeared in the patients. Among H. pylori-positive patients, DPM levels in asymptomatic patients were lower than those in symptomatic patients (P < .001). However, gastroscopic manifestations did not vary significantly between asymptomatic and symptomatic patients (P > .05). Patients infected with H. pylori showed no specific gastrointestinal symptoms. Patients with asymptomatic infection showed lower DPM levels, but their gastroscopic manifestations were similar to those of patients with symptomatic infection, and their lesions were more severe than H. pylori-negative people. H. pylori is highly contagious and is an important etiological factor for many kinds of disease. Eradication of H. pylori infection can decrease the cost of prevention, diagnosis, and treatment of H. pylori-associated diseases, but the eradication therapy may lead to adverse drug reactions. It has been suggested the treatment for asymptomatic infections should not overkill. Gastroscopic manifestations of asymptomatic patients were similar to those of symptomatic patients. Both of their lesions were more severe than H. pylori-negative individuals. We provide a theoretical basis for the consideration of the need for further gastroscopy and treatment in clinically asymptomatic infected patients.Keywords
Funding Information
- National Natural Science Foundation of China (82270594)
- National Natural Science Foundation for Youths of China (82002614, 82103151)
- Scientific Research Project of Hunan Provincial Health Commission (202103032097)
- Hunan Provincial Natural Science Foundation of China for Youths (2020JJ5609, 2021JJ40935)
This publication has 18 references indexed in Scilit:
- Risk factors of Helicobacter pylori infection in an urban community in Northeast Brazil and the relationship between the infection and gastric diseasesRevista da Sociedade Brasileira de Medicina Tropical, 2018
- Fifth Chinese National Consensus Report on the management ofHelicobacter pyloriinfectionHelicobacter, 2018
- Association between thyroid autoimmunity and Helicobacter pylori infectionThe Korean Journal of Internal Medicine, 2017
- Global burden of cancers attributable to infections in 2012: a synthetic analysisThe Lancet Global Health, 2016
- Systematic review of time trends in the prevalence of Helicobacter pylori infection in China and the USAGut Pathogens, 2016
- Diagnosis of Helicobacter pylori‐induced gastritis by serum pepsinogen levelsJournal of Gastroenterology and Hepatology, 2015
- World Gastroenterology Organisation Global GuidelineJournal of Clinical Gastroenterology, 2011
- Exploring the cost‐effectiveness ofHelicobacter pyloriscreening to prevent gastric cancer in China in anticipation of clinical trial resultsInternational Journal of Cancer, 2008
- Usefulness of Serum Pepsinogens in Helicobacter pylori Chronic Gastritis: Relationship With Inflammation, Activity, and Density of the BacteriumDigestive Diseases and Sciences, 2006
- Clinical usefulness of serum pepsinogens I and II, gastrin-17 and anti-Helicobacter pylori antibodies in the management of dyspeptic patients in primary careDigestive and Liver Disease, 2005